COVID-19-Associated Liver Injury. [Review]
Citation: Hepatic Medicine Evidence and Research. 15:1-9, 2023.PMID: 36852138Department: Internal Medicine Residency | MedStar Georgetown University Hospital/MedStar Washington Hospital CenterForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewYear: 2023ISSN:- 1179-1535
- https://orcid.org/0000-0003-3111-6383:
- Gildea, Daniel T
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | Available |
This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients. Copyright © 2023 Gildea et al.
English